CNS 2023

October 04-07, 2023
Vancouver, BC, Canada

Child Neurololgy Society

Explore more Neuroscience congress materials

Results(4)

Neuroscience

Nonseizure outcomes with cannabidiol in pediatric versus adult patients with Lennox-Gastaut syndrome and Dravet syndrome: subgroup analysis of BECOME, a caregiver survey

Author(s): Tracy Dixon-Salazar Ph.D., LGS Foundation

Neuroscience

Seizure outcomes with cannabidiol in pediatric versus adult patients with Lennox-Gastaut syndrome and Dravet syndrome: subgroup analysis of BECOME, a caregiver survey

Author(s): Timothy B. Saurer Ph.D., Jazz Pharmaceuticals

Neuroscience

Long-term safety and efficacy of add-on cannabidiol for seizures associated with tuberous sclerosis complex: 3-year results from the GWPCARE6 open-label extension

Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital

Neuroscience

Efficacy and safety of add-on cannabidiol for seizures associated with tuberous sclerosis complex in pediatric patients enrolled in a phase 3 trial with an open-label extension.

Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital

Neuroscience

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.